A phase II trial to investigate the efficacy of gacyclidine (OTO-311) in patients with tinnitus
Phase of Trial: Phase II
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Gacyclidine (Primary)
- Indications Tinnitus
- Focus Therapeutic Use
- 02 Mar 2017 According to an Otonomy media release, this trial is expected to start in the second half of 2017.
- 20 Nov 2015 New trial record
- 16 Nov 2015 This trial is expected to be initiated in the second half of 2016, according to an Otonomy media release.